Aboxitinib combined with glucocorticoids for the treatment of refractory pemphigus vulgaris: a case report

Institutions

Publication Details

Journal
Chinese Journal of Dermatology
Published
2024-11-04
DOI
https://doi.org/10.35541/cjd.20240323
Primary Topic
Autoimmune Bullous Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Aboxitinib combined with glucocorticoids for the treatment of refractory pemphigus vulgaris: a case report

Chinese Journal of Dermatology
Autoimmune Bullous Skin Diseases
article

Aboxitinib combined with glucocorticoids for the treatment of refractory pemphigus vulgaris: a case report

article en

Abstract

No abstract available for this paper.
Chinese Journal of Dermatology
Kunming Medical University (CN)
Zero hunger
Openalex Percentile: Top 68%
Autoimmune Bullous Skin Diseases
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Aboxitinib combined with glucocorticoids for the treatment of refractory pemphigus vulgaris: a case report · Chinese Journal of Dermatology (2024) | TGRS Research Map | TGRS